(19)
(11) EP 2 252 289 A1

(12)

(43) Date of publication:
24.11.2010 Bulletin 2010/47

(21) Application number: 09701670.3

(22) Date of filing: 16.01.2009
(51) International Patent Classification (IPC): 
A61K 31/401(2006.01)
A61K 31/7008(2006.01)
A61P 3/10(2006.01)
A61K 31/7004(2006.01)
A61K 45/06(2006.01)
(86) International application number:
PCT/JP2009/051023
(87) International publication number:
WO 2009/091082 (23.07.2009 Gazette 2009/30)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 17.01.2008 US 21777

(71) Applicant: Mitsubishi Tanabe Pharma Corporation
Osaka 541-8505 (JP)

(72) Inventors:
  • UETA, Kiichiro
    Osaka-shi, Osaka 541-8505 (JP)
  • ARAKAWA, Kenji
    Osaka-shi, Osaka 541-8505 (JP)
  • MATSUSHITA, Yasuaki
    Osaka-shi, Osaka 541-8505 (JP)

(74) Representative: Vossius & Partner 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) COMBINATION THERAPY COMPRISING SGLT INHIBITORS AND DPP4 INHIBITORS